Fimmic, founded in 2013, is a spin-off company from the Finnish Institute for Molecular Medicine at the University of Helsinki. The next-generation WebMicroscope AI Platform was launched in spring 2017 and has since been used in a wide range of image analysis applications globally.
CEO: Kaisa Helminen
2 articles with Fimmic
Cloud platform accelerates image processing and analysis by empowering pathologists and researchers worldwide with deep learning algorithms
Fimmic Raises 5M Euros Series A Round to Accelerate Scaling of its Deep Learning AI Cloud for Tissue Diagnostics
Fimmic announced today that it has closed a €5M investment round to accelerate scaling of its WebMicroscope AI Cloud for tissue diagnostics.